Takeda Pharmaceuticals International GmbH
    Industry / private company
    
    
        Location: 
        Zürich,
        
                Switzerland (CH)
                
    
 
        
    
    
    
        ROR: https://ror.org/002ysmy84
    
    
    
    
    
        
    
        
    
        
    
    
    
        
            
                
  
  Patient preferences in genetic newborn screening for rare diseases: study protocol (2024)
  Martin S, Angolini E, Audi J, Bertini E, Bruno LP, Coulter J, Ferlini A, et al.
  Journal article
            
                
  
  Genetic newborn screening and digital technologies: A project protocol based on a dual approach to shorten the rare diseases diagnostic path in Europe (2023)
  Garnier N, Berghout J, Zygmunt A, Singh D, Huang KA, Kantz W, Blankart CR, et al.
  Journal article